Fig. 2From: Chia (Salvia hispanica)-supplemented diet ameliorates non-alcoholic fatty liver disease and its metabolic abnormalities in humansEffects of chia supplementation on non-alcoholic fatty liver disease (NAFLD) prevalence (a), liver:spleen attenuation ratio (L:SAR) (b), plasma ALA (c), and dietary fiber intake (d). NAFLD was defined as L:SAR < 1.0, Δ represents percent change between basal and post-chia measurements. L:SAR ratio, ALA, and dietary fiber intake are expressed as median (interquartile range), *P < 0.01, **P < 0.001 (Wilcoxon matched-pairs signed-rank test)Back to article page